Newstral
Article
The New York Times on 2024-05-24 23:29
Ozempic cuts risk of chronic kidney disease complications, study finds
Related news
- Ozempic cuts risk of death from kidney disease, major study findspressherald.com
- Research stirs disagreement about chronic kidney diseaseArkansas Online
- Ozempic may help fight kidney disease, study findsOrlando Sentinel
- Bayer’s KERENDIA® (finerenone) Receives U.S. FDA Approval for Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetesabqjournal.com
- Plano’s Reata Pharmaceuticals halts chronic kidney disease drug developmentDallas News
- HThe stark connection between obesity and chronic kidney diseasehuroncountyview.mihomepaper.com
- RState Program to Help those with Chronic Kidney Diseaserocket-courier.com
- Metyos raises €2.3 pre-seed to combat chronic kidney diseasetech.eu
- Popular heartburn medications linked to chronic kidney diseaseChicago Tribune
- Startup building ‘biowearables’ for chronic kidney disease nets €2.3Mthenextweb.com
- PFDA approves Amgen’s Parsabiv drug to treat chronic kidney diseasepacbiztimes.com
- TMen with chronic kidney disease have worse outcomes than womentoday.uic.edu
- Popular heartburn medication linked to chronic kidney diseaseThe Columbian
- Urgent call to policymakers – make chronic kidney disease a public health priorityPolitico.eu
- SFDA approves drug for cats with chronic kidney disease, giving pet owners hopesilive.com
- Spokane doctor leads study finding high rates of chronic kidney disease with diabetes, disparities - Tue, 18 Oct 2022 PSTThe Spokesman-Review
- Chronic kidney disease bill introducedjournalrecord.com
- Overdiagnosis of chronic kidney diseasevillages-news.com
- Chronic Disease Conferencewsfa.com